Study finds no elevated risk of thyroid cancer among GLP1-RA users
A study has found no evidence that glucagon-like peptide 1 receptor agonist (GLP1-RA) use is associated with an increased ...
Medscape8d
Dipeptidyl Peptidase-4 Inhibitors: Clinical Data and Clinical Implications
The enzyme dipeptidyl peptidase-4 (DPP-4) prevents the inactivation of glucagon-like peptide-1 (GLP-1). Since GLP-1-based therapy is a promising novel treatment of type 2 diabetes, the strategy to ...
The American Journal of Managed Care9d
Collaboration to Transition Members to Preferred Formulary Dipeptidyl-Peptidase-4 Inhibitor
A collaboration between a drug plan and clinical pharmacists led to nearly 50% of members successfully switching to a preferred dipeptidyl-peptidase-4 inhibitor.
Daily4d
SGLT2 inhibitors may reduce atherothrombotic major CV events in diabetes patients: Study
A recent study conducted across public hospitals in Hong Kong highlighted the superiority of sodium-glucose cotransporter 2 ...
Nature10y
Design of angiotensin converting enzyme inhibitors
I was a young enzymologist looking for a new project, and immediately volunteered for this one, which involved a peptidase of apparently unique mechanism and an enzyme product of potentially great ...
Healthline7mon
Metformin & Oral Meds
They do this by blocking the action of an enzyme called dipeptidyl peptidase-4 (DPP-4). This enzyme breaks down hormones that reduce blood sugar levels. By interfering with this process ...